Back
Marker Therapeutics Vs. Perspective Therapeutics Industry Stock Comparison
Sell
39
MRKR
Marker Therapeutics
Last Price:
3.64
Seasonality Move:
8.13%
Sell
30
CATX
Perspective Therapeutics
Last Price:
9.93
Seasonality Move:
28.97%
Sell
39
Marker Therapeutics (MRKR)
is a Sell
Is Marker Therapeutics a Buy, Sell or Hold?
- The current Marker Therapeutics [MRKR] share price is $3.72. The Score for MRKR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- MRKR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $10.67. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MRKR Stock Price Chart
What is Marker Therapeutics's stock price today?
-
The Marker Therapeutics share price today is $3.72
The current trend is moderately bearish and MRKR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $10.67
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
MRKR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.17 | Buy |
| Relative Strength Index (14 RSI): | 50.39 | Buy |
| Chaikin Money Flow: | 6992 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.12 - 4.28) | Buy |
| Bollinger Bands (100): | (2.95 - 4.81) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.45 | Sell |
| Relative Strength Index (14 RSI): | 32.97 | Sell |
| Chaikin Money Flow: | -548254 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.5 - 12.8) | Sell |
| Bollinger Bands (100): | (11.26 - 14.34) | Sell |
MRKR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.86 | Sell |
| 20-day SMA: | 3.94 | Sell |
| 50-day SMA: | 3.26 | Buy |
| 200-day SMA: | 4.04 | Sell |
| 8-day EMA: | 3.9 | Sell |
| 20-day EMA: | 3.79 | Sell |
| 50-day EMA: | 3.61 | Buy |
| 200-day EMA: | 3.87 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.72 | Sell |
| 20-day SMA: | 11.96 | Sell |
| 50-day SMA: | 12.97 | Sell |
| 200-day SMA: | 12.78 | Sell |
| 8-day EMA: | 11.47 | Sell |
| 20-day EMA: | 11.93 | Sell |
| 50-day EMA: | 12.56 | Sell |
| 200-day EMA: | 11.75 | Sell |
Marker Therapeutics Earnings Growth & MRKR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.71 per share, and a decrease next year of $0.03 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.
Marker Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||